» Articles » PMID: 6259213

Mechanism of Adrenal Angiotensin II Receptor Changes After Nephrectomy in Rats

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1981 Apr 1
PMID 6259213
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

At 48 h after bilateral nephrectomy in rats there is a two- to threefold increase in the number of adrenal angiotensin II receptors and a decrease in Kd of smooth muscle angiotensin II receptors. These changes have been attributed to the absence of circulating angiotensin II. Serum K+, which increases after nephrectomy may be an important and overlooked modulator. Therefore, the present experiments were designed to assess the role of K+ as a regulator of angiotensin II receptors after nephrectomy. Serum K+ was controlled with Na polystyrene sulfonate (Kayexalate), a resin designed to exchange Na+ for K+ in the gastrointestinal tract. Acutely nephrectomized rats were divided into two groups: experimental animals received Kayexalate resin every 12 h for four doses, and controls received Kayexalate exchanged with KCl in vitro before gavage. There was a significant positive correlation serum K+ and aldosterone (r = 0.78, P less than 0.001). Kayexalate maintained a normal serum K+ of 5.9 +/- 0.2 meq/liter (n = 27), aldosterone 25 +/- 3 ng/dl (n = 27) and adrenal receptor concentration of 934 +/- 156 fmol/mg protein (n = 4). Control animals had significantly higher serum K+ of 10.5 +/- 0.4 meq/liter (n = 23), aldosterone 435 +/- 32 (n = 23), and adrenal receptors of 2726 +/- 235 fmol/mg protein (n = 4). There was a linear relationship between serum K+ and number of adrenal receptors (r = 0.87). No such relationship was present in uterine smooth muscle. Therefore, these studies demonstrate that K+ modulates the number of adrenal but not smooth muscle angiotensin II receptors after nephrectomy. This is the first evidence that potassium modulates angiotensin II receptors independently of changes in angiotensin II blood levels.

Citing Articles

Pharmacological strategies to manage hyperkalaemia: out with the old, in with the new? Not so fast….

Carrero J, Sood M, Gonzalez-Ortiz A, Clase C Clin Kidney J. 2023; 16(8):1213-1220.

PMID: 37529644 PMC: 10387386. DOI: 10.1093/ckj/sfad089.


Adverse Gastrointestinal Effects with Kayexalate or Kalimate: A Comprehensive Review.

Wu Y, Chou J, Lai H, Su G, Cheng K, Chen T Clin Exp Gastroenterol. 2021; 14:1-18.

PMID: 33469334 PMC: 7810591. DOI: 10.2147/CEG.S278812.


Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study.

Laureati P, Xu Y, Trevisan M, Schalin L, Mariani I, Bellocco R Nephrol Dial Transplant. 2019; 35(9):1518-1526.

PMID: 31377791 PMC: 7473802. DOI: 10.1093/ndt/gfz150.


Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells.

Ullian M, Linas S J Clin Invest. 1989; 84(3):840-6.

PMID: 2760215 PMC: 329727. DOI: 10.1172/JCI114244.

References
1.
Meyer P, Papadimitriou A, Worcel M . Specific supersensitivity of smooth muscle to angiotensin II after nephrectomy. Br J Pharmacol. 1974; 51(3):435-9. PMC: 1776789. DOI: 10.1111/j.1476-5381.1974.tb10679.x. View

2.
Douglas J, Michailov M, Khosla M, BUMPUS F . Comparative receptor-binding properties of heptapeptide and octapeptide antagonists of angiotensin II in rat adrenal glomerulosa and uterine smooth muscle. Endocrinology. 1980; 106(1):120-4. DOI: 10.1210/endo-106-1-120. View

3.
Devynck M, Rouzaire-Dubois B, Chevillotte E, Meyer P . Variations in the number of uterine angiotensin receptors following changes in plasma angiotensin levels. Eur J Pharmacol. 1976; 40(1):27-37. DOI: 10.1016/0014-2999(76)90350-2. View

4.
BLAQUIER P, HOOBLER S, Schroeder J, Gomez A, KREULEN T . Effect of bilateral nephrectomy on pressor response to renin. Am J Physiol. 1962; 203:339-43. DOI: 10.1152/ajplegacy.1962.203.2.339. View

5.
McKenzie J, Clements J . Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab. 1974; 38(4):622-7. DOI: 10.1210/jcem-38-4-622. View